ID: ALA203468

Max Phase: Preclinical

Molecular Formula: C21H26O3

Molecular Weight: 326.44

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  CC(C)COc1ccc(C(=O)c2ccc(OCC(C)C)cc2)cc1

Standard InChI:  InChI=1S/C21H26O3/c1-15(2)13-23-19-9-5-17(6-10-19)21(22)18-7-11-20(12-8-18)24-14-16(3)4/h5-12,15-16H,13-14H2,1-4H3

Standard InChI Key:  QHKIDSWZKIBTHP-UHFFFAOYSA-N

Associated Targets(Human)

Transcription factor AP1 124 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 326.44Molecular Weight (Monoisotopic): 326.1882AlogP: 4.99#Rotatable Bonds: 8
Polar Surface Area: 35.53Molecular Species: NEUTRALHBA: 3HBD: 0
#RO5 Violations: 0HBA (Lipinski): 3HBD (Lipinski): 0#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: CX LogP: 5.61CX LogD: 5.61
Aromatic Rings: 2Heavy Atoms: 24QED Weighted: 0.64Np Likeness Score: -0.37

References

1. Tsuchida K, Chaki H, Takakura T, Kotsubo H, Tanaka T, Aikawa Y, Shiozawa S, Hirono S..  (2006)  Discovery of nonpeptidic small-molecule AP-1 inhibitors: lead hopping based on a three-dimensional pharmacophore model.,  49  (1): [PMID:16392794] [10.1021/jm050550d]

Source